MedPlus Weekly breakout done
Buy near CMP 730
Long term Target 950-1370+
Only for educational purposes
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
8.40 INR
654.73 M INR
56.25 B INR
48.61 M
About MEDPLUS HEALTH SERV LTD
Sector
Industry
CEO
Madhukar Reddy Gangadi
Website
Headquarters
Hyderabad
Founded
2006
ISIN
INE804L01022
FIGI
BBG013YXGVH8
MedPlus Health Services Ltd. engages in the provision of operation of pharmacies. It operates through the following segments: Retail, Diagnostics, and Others. The Retail segment focuses on the sale of pharmaceuticals and general items. The Diagnostics segment involves the pathology and radiology services. The Others segment includes insurance broking business. Its pharmacies carry medicines, vitamins, medical devices, test kits, and fast-moving consumer goods. It also conducts pathological services and distributes medical and surgical supplies through RiteCure and its online pharmacy Medplus Mart. The company was founded by Madhukar Gangadi in 2006 and is headquartered in Hyderabad, India.
MEDPLUSMedplus has given trend-line breakout with increased market participation. Seems promising for midterm trading. Trend reversal is quite possible after almost a year's consolidation.
MEDPLUS 1D Swing Trader ! Price Action Follower!
Join for High potential break out chart updates.
Disclaimer-I am not SEBI registered or authorized analysts. The charts and level posted will be my personal view only.
# MARK MY TRADE
MEDPLUSMEDPLUS looks good --- Weekly Close above 735 then chances of 950 to 1250, with a strong support of 630.
Just Sharing to build my confidence. No suggestion of buying stock.
MEDPLUS - Trendline and Symmetrical Triangle breakoutPrice decline since 2022 and the price consolidate since Feb 2024 inside the triangle and it breakout that and black color trendline this week. As this stock in downrange, this need to be consider very carefully or view this for educational purpose.
MedPlus Buy at CMP near 730
Weekly breakout done
Long term Target 960-1370+
Only for educational purpose
medplus share longNSE:MEDPLUS
medplus share long
note:
don't buy / sell this stock, please trade with your own research and responsibility.
Did you Ride the Medplus Momentum?September 4, 2024
On Sep 2, 2024, we had posted our analysis of a short-term uptrend in Medplus. Here is the chart we initially published
As anticipated by us, Medplus breached the 50%, 61.8% and 78.6% Fib levels in just 2 trading days.
From Rs. 685, the stock zoomed to Rs. 729, giving around
Ride the Medplus Momentum: Short-Term Trade AlertSeptember 2, 2024
Medplus seems to have completed a triple correction and is on the rise.
It created a demand zone between Rs 595 and Rs 605 level.
The stock retested the demand zone for the second time in the last week of August, and as expected, buyers came and moved the stock up toward the
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MEDPLUS is 741.45 INR — it has increased by 0.91% in the past 24 hours. Watch MEDPLUS HEALTH SERVICES LIMITE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange MEDPLUS HEALTH SERVICES LIMITE stocks are traded under the ticker MEDPLUS.
MEDPLUS stock has risen by 5.16% compared to the previous week, the month change is a 11.49% rise, over the last year MEDPLUS HEALTH SERVICES LIMITE has showed a −9.56% decrease.
We've gathered analysts' opinions on MEDPLUS HEALTH SERVICES LIMITE future price: according to them, MEDPLUS price has a max estimate of 1,100.00 INR and a min estimate of 830.00 INR. Watch MEDPLUS chart and read a more detailed MEDPLUS HEALTH SERVICES LIMITE stock forecast: see what analysts think of MEDPLUS HEALTH SERVICES LIMITE and suggest that you do with its stocks.
MEDPLUS reached its all-time high on Jan 20, 2022 with the price of 1,343.00 INR, and its all-time low was 570.00 INR and was reached on Nov 10, 2022. View more price dynamics on MEDPLUS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MEDPLUS stock is 4.42% volatile and has beta coefficient of −0.19. Track MEDPLUS HEALTH SERVICES LIMITE stock price on the chart and check out the list of the most volatile stocks — is MEDPLUS HEALTH SERVICES LIMITE there?
Today MEDPLUS HEALTH SERVICES LIMITE has the market capitalization of 88.64 B, it has increased by 2.16% over the last week.
Yes, you can track MEDPLUS HEALTH SERVICES LIMITE financials in yearly and quarterly reports right on TradingView.
MEDPLUS HEALTH SERVICES LIMITE is going to release the next earnings report on Jan 31, 2025. Keep track of upcoming events with our Earnings Calendar.
MEDPLUS net income for the last quarter is 387.36 M INR, while the quarter before that showed 143.63 M INR of net income which accounts for 169.69% change. Track more MEDPLUS HEALTH SERVICES LIMITE financial stats to get the full picture.
No, MEDPLUS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 21.72 K employees. See our rating of the largest employees — is MEDPLUS HEALTH SERVICES LIMITE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDPLUS HEALTH SERVICES LIMITE EBITDA is 4.16 B INR, and current EBITDA margin is 6.33%. See more stats in MEDPLUS HEALTH SERVICES LIMITE financial statements.
Like other stocks, MEDPLUS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDPLUS HEALTH SERVICES LIMITE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDPLUS HEALTH SERVICES LIMITE technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDPLUS HEALTH SERVICES LIMITE stock shows the buy signal. See more of MEDPLUS HEALTH SERVICES LIMITE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.